Earlier this month, the Trump administration said it was terminating $500 million in mRNA vaccine research and shifting its focus to other approaches, including a previously announced “whole-virus” vaccine platform dubbed “Generation Gold Standard.” “Generation Gold Standard is a paradigm shift,” Dr. Jay Bhattacharya, the director of the National Institutes of Health, said in a news release in May touting the next research initiative . “It extends vaccine protection beyond strain-specific

See Full Page